European Association of Urology Annual Congress (EAU23)
EAU 2023 Prostate Cancer
- EAU 2023: State-of-the-Art Lecture: Patient-Related Factors That Guide Treatment Decisions
- EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Systemic Therapy: What and for how long?
- EAU 2023: State-of-the-Art Lecture: Optimal Treatment Sequencing in the Area of Triplet Therapies for Hormone-Sensitive Disease
- EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Subtypes of Prostate Cancer and How They Change our Management
- EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Arguments for a Surgical Approach +/- Radiotherapy +/- Systemic Treatment
EAU 2023 Bladder Cancer
- EAU 2023: Blue Light Cystoscopy Delays Time to Recurrence in Non-Muscle Invasive Bladder Cancer Patients Treated in a Real-World Setting
- EAU 2023: Immunological Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer
- EAU 2023: In Young Patients, Is Prostate-Sparing Radical Cystectomy a Safe Option for Muscle Invasive Bladder Cancer? What About Reproductive Organ-Sparing in Women? Debate
- EAU 2023: Is There a Role for Local Therapy to the Bladder in Patients with Oligometastatic Disease?
- EAU 2023: Clinical Staging for Bladder Cancer: Have Imaging Techniques Reached a Point Where We Can Avoid TURBT – at Initial Diagnosis? After Neoadjuvant Therapy?
EAU 2023 Kidney Cancer
- EAU 2023: European Urology Oncology Lecture: The Future of Systemic Treatment in Patients with Locally Advanced and Metastatic Renal Cell Carcinoma
- EAU 2023: Utility of Adjuvant Immunotherapy in High-Risk Non-Metastatic Renal Cell Carcinoma: A Real-World Experience Using National Cancer Database Analysis
- EAU 2023: Refining the Indication for Adjuvant Pembrolizumab in Patients with Clear Cell Renal Cell Carcinoma at High Risk of Recurrence Using a Risk-Adapted Approach: A Contemporary Multicenter Study
- EAU 2023: Patient Experience with Recurrence of Renal Cell Carcinoma
- EAU 2023: UroCCR Study 120: Development of an Individual Postoperative Prediction Model for Kidney Cancer Recurrence Using Machine Learning
EAU 2023 Press Releases
- New Data Presented at EAU 2023 Highlight the Effects of Blue Light Cystoscopy in Bladder Cancer
- Delaying Treatment for Localised Prostate Cancer Does Not Increase Mortality Risk, Trial Shows
- Difference Between “Growers” and “Showers” Revealed
- UK Study Finds Vasectomies Are Even Safer than Reported
- Urine Gene Test Can Predict Bladder Cancer Years Before Diagnosis
EAU 2023 Upper Tract Urothelial Carcinoma
- EAU 2023: State-of-the-Art Lecture: Immunotherapy in Locally Advanced and Metastatic UTUC: A Reality?
- EAU 2023: Is It Possible to Consider Systematic Immediate Intravesical Instillation after Radical Nephroureterectomy?
- EAU 2023: State-of-the-Art Lecture: Evidence for Neoadjuvant Treatment Before Radical Nephroureterectomy
- EAU 2023: State-of-the-Art Lecture: Improvement in Technologies and Drugs to Support Kidney Sparing Surgery
- EAU 2023: State-of-the-Art Lecture: Role of Systemic Chemotherapy After Radical Nephroureterectomy